Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지

Effects of Preoperative Radiotherapy for $T_2,\;T_3$ Distal Rectal Cancer

$T_2,\;T_3$ 하부직장암의 수술 전 방사선치료 효과

  • Kang Ki Mun (Department of Therapeutic Radiology, Gyengsang National University, College of Medicine) ;
  • Choi Byung Ock (Department of Therapeutic Radiology, The Catholic University of Korea, College of Medicine) ;
  • Jang Hong Seok (Department of Therapeutic Radiology, The Catholic University of Korea, College of Medicine) ;
  • Kang Young Nam (Department of Therapeutic Radiology, The Catholic University of Korea, College of Medicine) ;
  • Chai Gyu Young (Department of Therapeutic Radiology, Gyengsang National University, College of Medicine) ;
  • Choi Ihl Bohng (Department of Therapeutic Radiology, The Catholic University of Korea, College of Medicine)
  • 강기문 (경상대학교 의과대학 치료방사선과학교실) ;
  • 최병옥 (가톨릭대학교 의과대학 치료방사선과학교실) ;
  • 장홍석 (가톨릭대학교 의과대학 치료방사선과학교실) ;
  • 강영남 (가톨릭대학교 의과대학 치료방사선과학교실) ;
  • 채규영 (경상대학교 의과대학 치료방사선과학교실) ;
  • 최일봉 (가톨릭대학교 의과대학 치료방사선과학교실)
  • Published : 2002.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Preoperative radiotherapy has been used to induce tumor regression and allow complete resection of rectal cancer with a sphincter preservation surgery. This study was performed to determine the effectiveness of preoperative radiotherapy for $T_2,\;T_3$ distal rectal carcinoma. Materials and Methods : From November 1995 to June 1997, fifteen patients with invasive distal rectal cancer were treated with preoperative radiotherapy followed by sphincter preservation surgery. Classification by preoperative T stage consisted of 7 $T_2$ and 8 $T_3$ tumors. Radiation therapy was delivered with 6 MV and 15 MV linear accelerator, at 1.8 Gy fractions for 5 days per week. Total radiation doses were 45 Gy to 50.4 Gy (median : 50.4 Gy). Sphincter preservation surgery was peformed $4\~6$ weeks after the completion of radiotherapy. Median follow-up was 22 months (range : $16\~37\;months$). Results : One patient $(6.7\%)$ had a complete pathologic response. Comparing the stage at the diagnostic workup with the pathologic stage, tumor downstaging of T stages occurred in 11 of 15 patients $(73.3\%)$ and $N_1$ stages occurred in 2 of 5 patients $(40\%)$. No patient developed progressive disease undergoing treatment. Two patients suffered local recurrence at 7 and 20 months, and one a distant metastasis at 30 months. No grade 3 or 4 toxicity was observed. Conclusion : Our experience suggests that preoperative radiotherapy followed by sphincter preservation surgery is well tolerated, and can significantly reduce the tumor burden for $T_2\;T_3$ distal rectal cancer.

목적 : $T_2,\;T_3$ 하부직장암에서 항문 괄약근 보전술을 위한 수술 전 방사선치료를 시행하여 그에 따른 효과를 알아보고자 하였다. 대상 및 방법 : 1995년 11월부터 1997년 6월까지 하부 직장암으로 진단받고 수술 전 방사선치료 후 항문 괄약근 보존술을 시행한 15례를 대상으로 하였다. $T_2$가 7례, $T_3$는 8례였다. 방사선치료는 선형가속기 6 MV와 15 MV X-ray를 이용하여 주 5회, 1회 1.8 Gy로 총 조사선량은 $45\~50.4\;Gy$까지 조사하였다(중앙선량:50.4 Gy). 항문 괄약근 보존술은 방사선치료 후 $4\~6$주 뒤에 시행하였다. 추적관찰기간은 $16\~37$개월이었고 중앙값은 22개월이었다. 결과 : 1례$(6.7\%)$에서 수술 후 병리학적으로 병변의 완전 소실을 보였다. 수술 전 임상 소견과 수술 후 병리학적 소견을 비교시, 1병기는 15례 중 11례$(73.3\%)$에서 병기감소를 보였으며 림프절 전이가 관찰되었던 5례 중 2례에서 림프절이 관찰되지 않았다. 치료동안에 병변이 진행된 경우는 없었다. 국소 재발은 2례$(13.3\%)$로 방사선치료 후 7개월, 17개월에 각각 발생하였으며 그 중 1명은 방사선치료 후 30개월 때 원격전이를 보였다. 합병증으로 Grade 3 또는 4는 없었다. 결론 : $T_2,\;T_3$ 하부직장암에서 항문 괄약근 보존술을 위한 수술 전 방사선치료가 비교적 안전하고 병변을 줄이는데 효과적인 치료방법임을 알 수 있었다.

Keywords

References

  1. Wiggers T, de Vries MR, Veeze-Kuypers B. Surgery for local recurrence of rectal carcinoma. Dis Colon Rectum 1996;39:323-328 https://doi.org/10.1007/BF02049476
  2. Harnsberger JR, Vernava VM III, Longo WE. Radical abdominopelvic lymphadenectomy : historic perspective and current role in the surgical management of rectal cancer. Dis Colon Rectum 1994;37:73-87 https://doi.org/10.1007/BF02047218
  3. Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-646 https://doi.org/10.1056/NEJMoa010580
  4. Frykholm GJ, GIimeIius B, PahIman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564-572 https://doi.org/10.1007/BF02049863
  5. Marijnen CA, Nagtegaal ID, Kranenbarg EK, et aI. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001;19:1976-1984
  6. Fortunato L, Ahmad NR, Yeung RS, et al. Long-term follow-up of local excision and radiation therapy for invasive rectal cancer. Dis Colon Rectum 1995;38:1193-1199 https://doi.org/10.1007/BF02048336
  7. Ota DM, Skibber J, Rich TA. M.D. Anderson Cancer Center experience with local excision and multimodality therapy for rectal cancer. Surg Oncol Clin North Am 1992;1:147-152
  8. MendenhaII WM, Rout WR, Lind DS, et aI. Role of radiation therapy in the treatment of resectable rectal adenocarcinoma. J Surg Oncol 2002;79:107-117 https://doi.org/10.1002/jso.10048
  9. WoImark N, Wieand HS, Hyams DM, et aI. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum : National Surgical Adjuvant Breast and Bowel Project protocol R-02. J Natl Cancer lnst 2000;92:388-396 https://doi.org/10.1093/jnci/92.5.388
  10. Minsky BD, Cohen AM, Enker WE, Paty P. Sphincter preservation with preoperative radiation therapy and coloanal anastomosis. Int J Radiat Oncol Biol Phys 1995;31:553-559 https://doi.org/10.1016/0360-3016(94)00375-U
  11. Russell AH, Harris J, Rosenberg PJ, er aI. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum : long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys 2000;46:313-322 https://doi.org/10.1016/S0360-3016(99)00440-X
  12. WiIIiams NS, Johnson D. The quality of life after rectal excision for low rectal cancer. Br J Surg 1983;70:460-462 https://doi.org/10.1002/bjs.1800700805
  13. Camma C, Giunta M, Fiorica F, PagIiaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer. A Meta-analysis. JAMA 2000;284:1008-1015 https://doi.org/10.1001/jama.284.8.1008
  14. Mohiuddin M, Regine WF, Marks GJ, Marks JW. Highdose preoperative radiation and the challenge of sphincterpreservation surgery for cancer of the distal 2 cm of the rectum Int J Radiat Oncol Biol Phys 1998;40:569-574
  15. Luna-Perez P, Rodriguez-Ramirez S, Rodriguez-Coria DF, et aI. Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma. World J Surg 2001;25:1006-1011 https://doi.org/10.1007/s00268-001-0071-y
  16. Rullier E, Goffre B, Bonnel C, Zerbib F, Caudry M, Saric J. Preoperative radiohemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg 2001;234:633-640 https://doi.org/10.1097/00000658-200111000-00008
  17. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the european organization for research and treatment of cancer (EROTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346 https://doi.org/10.1016/0360-3016(95)00060-C
  18. Kodner IJ, Gilley MT, Shemesh EL, et aI. Radiation therapy as definitive treatment for selected invasive rectal cancer. Surgery 1993;114:850-856
  19. Metzger U. Adjuvant therapy for colon and rectal cancer. NIH Consensus Development Conference. Eur J Cancer 1990;26:753-755
  20. Gerard A, Buyse M, Nordlinger B, et aI. Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final result of a randomized study of the European Organization for Research snd Treatment of Cancer (EORTC). Ann Surg 1988;208:606-614
  21. Danzi M, FeruIano GP, Abate S, et aI. Male sexual function after abdominoperineal resection for rectal cancer. Dis Colon Rectum 1983;26:665-668 https://doi.org/10.1007/BF02553339
  22. Ruo L, Guillem JG, Minsky BD, Quan SH, Paty PB, Cohen AM. Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers. Int J Colorectal Dis 2002;17:54-58 https://doi.org/10.1007/s003840100327
  23. HoIm T, Johansson H, Rutqvist LE, Cedermark B. Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer. Br J Surg 2001;88:839-843 https://doi.org/10.1046/j.0007-1323.2001.01789.x
  24. Rich TA, Skibber JM, Ajani PM, et aI. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 1995;32:1025-1029 https://doi.org/10.1016/0360-3016(95)00020-Y
  25. Wagman R, Minsky BD, Cohen AM, et aI. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis : Iong term follow-up. Int J Radiat Oncol Biol Phys 1998; 42;51-57
  26. Janjan NA, Khoo VS, Abbruzzese J, et aI Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer : the M.D. Ander son Cancer Center experience. Int J Radiat Oncol Biol Phys 1999;44:1027-1038
  27. Grann A, Feng C, Wong D, et aI. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2001;49:987-995 https://doi.org/10.1016/S0360-3016(00)01529-7
  28. Maghfoor I, Wilkers J, Kuvshinoff B, et aI. Neoadjuvant chemoradiotherapy with shincter sparing sparing surgery for low lying rectal cancer. Proc ASCO 1997;16:274